Active Ingredient: LANSOPRAZOLE
Proprietary Name: LANSOPRAZOLE
Dosage Form; Route of Administration: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE; ORAL
Strength: 15MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A200816
Product Number: 001
Approval Date: Nov 27, 2018
Applicant Holder Full Name: ZYDUS PHARMACEUTICALS USA INC
Marketing Status:
Prescription
Patent and Exclusivity Information
Active Ingredient: LANSOPRAZOLE
Proprietary Name: LANSOPRAZOLE
Dosage Form; Route of Administration: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE; ORAL
Strength: 30MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A200816
Product Number: 002
Approval Date: Nov 27, 2018
Applicant Holder Full Name: ZYDUS PHARMACEUTICALS USA INC
Marketing Status:
Prescription
Patent and Exclusivity Information